Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

SHE/300244 stock hub

SHE/300244 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/300244is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

12.9B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/300244

In the news

Latest news · SHE/300244

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E30

P25 17.1P50 24.2P75 37.8

Trailing P/E99.6

P25 23.5P50 41.3P75 83.2

ROE2.8

P25 -0.9P50 4.1P75 8.8

ROIC6.5

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/300244 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

230

Groups with data

Currency

CNY

Showing 230 of 230 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	8,773
Employees Change	-2,070%
Employees Change Percent	-19.09
Enterprise value	CNY 14.4B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Diagnostics & Research
Isin	CNE1000015N1
Last refreshed	2026-05-10
Market cap	CNY 12.9B
Price	CNY 21.09
Price currency	CNY
Rev Per Employee	1,137,338x
Sector	Healthcare
Sic	8071
Symbol	she/300244
Website	https://www.dazd.cn

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1%
EV Earnings	111.5x
EV/EBIT	23.19x
EV/EBITDA	13.91x
EV/FCF	8.1x
EV/Sales	1.45x
FCF yield	13.83%
Forward P/E	30.01x
P/B ratio	1.49x
P/E ratio	99.59x
P/S ratio	1.29x
PE Ratio10 Y	104.66x
PE Ratio5 Y	202.05x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	6.24%
EBITDA Margin	8.82%
FCF margin	17.87%
Gross margin	28.8%
Gross Profit	CNY 2.9B
Gross Profit Growth	-11.27%
Gross Profit Growth Q	6.09%
Gross Profit Growth3 Y	-23.54%
Gross Profit Growth5 Y	-9.13%
Net Income	CNY 129.4M
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Net Income Growth3 Y	-46.4%
Net Income Growth5 Y	-35.22%
Pretax Margin	3.91%
Profit Margin	1.3%
Profit Per Employee	CNY 14,754
Profitable Years	1
ROA	2.66
Roa5y	6.06
ROCE	6.1
ROE	2.82
Roe5y	9.95
ROIC	6.53
Roic5y	12.96

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-2.99%
Cagr1y	45%
Cagr3y	-3.93%
Cagr5y	-7.69%
Div CAGR10	20.36%
Div CAGR3	88.21%
Div CAGR5	47.71%
EPS Growth Quarters	2
EPS Growth Years	1
EPS Growth3 Y	-46
EPS Growth5 Y	-34.99
FCF Growth	90.79%
FCF Growth3 Y	7.27%
FCF Growth5 Y	13.52%
OCF Growth	55.83%
OCF Growth10 Y	37.54%
OCF Growth3 Y	-5.15%
OCF Growth5 Y	6.91%
Revenue Growth	-13.9x
Revenue Growth Q	-5x
Revenue Growth Years	0x
Revenue Growth3 Y	-19.13x
Revenue Growth5 Y	-3.6x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.68
Assets	CNY 14.1B
Cash	CNY 2.1B
Current Assets	CNY 10.6B
Current Liabilities	CNY 3.9B
Debt	CNY 1.5B
Debt EBITDA	CNY 1.48
Debt Equity	CNY 0.18
Debt FCF	CNY 0.86
Equity	CNY 8.7B
Interest Coverage	4.11
Liabilities	CNY 5.4B
Long Term Assets	CNY 3.5B
Long Term Liabilities	CNY 1.5B
Net Cash	CNY 593.6M
Net Cash By Market Cap	CNY 4.61
Net Debt EBITDA	CNY -0.67
Net Debt Equity	CNY -0.07
Net Debt FCF	CNY -0.33
Tangible Book Value	CNY 6.1B
Tangible Book Value Per Share	CNY 9.96
WACC	8.35

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.73
Inventory Turnover	4.63
Net Working Capital	CNY 5.2B
Quick ratio	2.22
Working Capital	CNY 6.7B
Working Capital Turnover	CNY 1.45

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.39%
Dividend Growth	1,400%
Dividend Growth Years	0%
Dividend per share	CNY 0.35
Dividend Years	14
Dividend Yield	1.66%
Last Dividend	CNY 0.25
Payout Ratio	193.97%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-26.15%
1Y total return	44.96%
200-day SMA	18.2
3Y total return	-11.33%
50-day SMA	19.76
50-day SMA vs 200-day SMA	50over200
5Y total return	-32.96%
All Time High	86.97
All Time High Change	-75.75%
All Time High Date	2015-06-05
All Time Low	3.55
All Time Low Change	494.75%
All Time Low Date	2012-01-19
ATR	0.9
Beta	0.79
Beta1y	1.06
Beta2y	1.51
Ch YTD	33.06
High	22.4
High52	33.3
High52 Date	2026-01-14
High52ch	-36.67%
Low	20.44
Low52	13.52
Low52 Date	2025-06-23
Low52ch	55.99%
Ma50ch	6.75%
Price vs 200-day SMA	15.9%
RSI	64.15
RSI Monthly	55.61
RSI Weekly	56.49
Sharpe ratio	0.97x
Sortino ratio	1.88
Total Return	2.05%
Tr YTD	33.06
Tr1m	14.56%
Tr1w	5.24%
Tr3m	-10.48%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 622.3M
Operating Income Growth	-7.04
Operating Income Growth Q	176.9
Operating Income Growth3 Y	-33.37
Operating Income Growth5 Y	-17.95
Operating margin	6.24

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	425,278,649%
Net Borrowing	-789,833,857
Shares Insiders	28.67%
Shares Institutions	15.96%
Shares Out	611,099,436
Shares Qo Q	0.08%
Shares Yo Y	-0.39%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 1.8B
Average Volume	26,630,598.25x
Bv Per Share	10.68
CAPEX	CNY -251.1M
Ch10y	-34.21
Ch1m	14.56
Ch1w	5.24
Ch1y	42.5
Ch3m	-10.48
Ch3y	-19.66
Ch5y	-39.74
Ch6m	30.91
Change	2.88%
Change From Open	0.33
Close	20.5
Days Gap	2.54
Depreciation Amortization	278,649,394
Dollar Volume	1,564,291,002
Earnings Date	2026-04-22
EBIT	CNY 622.3M
EBITDA	CNY 880.1M
EPS	CNY 0.21
F Score	7
FCF	CNY 1.8B
FCF EV Yield	12.35x
FCF Per Share	CNY 2.92
Financing CF	-1,332,996,399
Fiscal Year End	December
Founded	1,996
Goodwill	386,015,206
Graham Number	7.13245
Graham Upside	-66.18
Income Tax	CNY 144.5M
Investing CF	-361,529,996
Is Primary Listing	1
Last Earnings Date	2026-04-22
Last Report Date	2026-03-31
Last Split Date	2016-05-09
Last Split Type	Forward
Lynch Fair Value	CNY 1.06
Lynch Upside	-94.98
Ma150	18.82
Ma150ch	12.08%
Ma20	19.34
Ma20ch	9.08%
Net CF	332,335,574
Next Earnings Date	2026-08-21
Open	21.02
P FCF Ratio	7.23
P OCF Ratio	6.34
Payment Date	2025-06-18
Position In Range	33.16
Ppne	1,379,625,948
Price Date	2026-05-08
Price EBITDA	CNY 14.64
Ptbv Ratio	2.12
Relative Volume	3.14x
Revenue	9,977,866,303x
Tax By Revenue	1.45x
Tax Rate	37.04%
Tr6m	30.91%
Volume	74,172,167

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/300244 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.7%

$0.35 annual per share

Payout ratio

+194.0%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+47.7%

0 consecutive years of growth

Total shareholder yield

+2.1%

Dividend yield + buyback yield combined

Performance

SHE/300244 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/300244?

Insider, institutional, and short-interest positioning.

Institutional ownership

+16.0%

Share of float held by funds and institutions

Insider ownership

+28.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.4%

Negative means the company is buying back shares.

Technical

SHE/300244 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

64.1

Neutral momentum band

Price vs 200-day MA

+15.9%

50/200-day relationship not available

Beta (5Y)

0.79

Less volatile than the market

Sharpe ratio

0.97

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/300244

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/300244 stock rating?

she/300244 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/300244 analysis?

The full report lives at /stocks/she/300244/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/300244?

The latest report frames she/300244 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/300244 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.